Skip to content
MarketScale
‹ Back to IndustriesHealthcare

July Job Report Reveals Records and Reservation

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June. Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

U.S. labor force participation reached a record high in the month of July. Unemployment remained at 3.7% according to the latest jobs report from Bureau of Labor Statistics, released Friday, Aug. 2. Wages also increased 3.2% overall, an increase from June.

Approximately 164,000 Non-farm payroll additions were made in July, while private-sector payrolls modestly under-preformed Dow Jones and Moody’s expectations, at 148,000 for the month.

The strong job numbers are, however, a departure from consistent payroll increases of 200,000-plus the country experienced in 2018 and the first quarter of 2019. So far this year, average monthly job additions stand at 165,000, according to the Wall Street Journal. Analysts continue to point towards a trend stagnation in job growth for the remainder of the fiscal year.

Looking Ahead by Looking Back

Professional and technical services added 30,800 jobs and the health care sector added 30,400 accounting for two of the biggest payroll growths in July. Financial activities payrolls rose by 18,000 while the mining industry reported a loss of 5,000 jobs.

Today’s jobs report also significantly revised earlier numbers from what was supposedly a strong month of growth in June. The June payroll gain of 224,000 was reduced to 193,000. May’s sluggish job numbers have also been reduced from the reported 72,000 jobs down to 62,000.

Photo courtesy of the United States Bureau of Labor Statistics.

The record increase in workforce participation comes amid news that retailers like Lowe’s, which just announced thousands of layoffs at its stores, are continuing to close and reduce costs. This year alone, more than 7,000 store closures have been announced by US retailers–a staggering number that some analysts predict could reach up to 12,000 by the end of the year.

Who’s Winning, Who’s Losing?

Small businesses, specifically those with less than 20 employees, reported negative payroll numbers for the third consecutive month. They continue to struggle with labor shortages and competition from online retailers that are contributing to this decline.

Manufacturing employment had another month of modest job growth, with the country adding 16,000 new jobs. The American manufacturing industry has seen one of the most difficult periods for job growth over the past two quarters. This report comes in the midst of ongoing trade disputes and softening of the global market. US manufacturing work hours hit its lowest mark since 2011.

In the wake of a new round of tariffs on China, set to go in effect September 1st, the trade deficit between the two countries decreased 0.3% to 55.2 billion. Markets will be vigilant of the impact this new round of tariffs will have on American consumers along with worries of a global economic slowdown as the Federal Reserve voted Wednesday to cut their interest rate a quarter of a percent.

For the latest news, head to our industries pages! You can also follow us on Twitter @MarketScale for up-to-the-minute updates! Join the conversation in on Market Leaders LinkedIn Groups!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512